Westaim Corp V.WED

Alternate Symbol(s): WEDXF

Financial Services Asset Management

The Westaim Corporation is a Canadian investment company specializing in providing long-term capital to businesses operating primarily within the global financial services industry. The Company invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Its strategy is to pursue investment opportunities with a focus towards the financial services industry and grow shareholder value over the long term. Its investments include significant interests in Arena and the Arena FINCOs. The Arena FINCOs are private companies which include specialty finance companies that primarily purchase fundamental-based, asset-oriented credit and other investments for their own account. Arena consists of two main business lines: Arena Investors and Arena Institutional Services (AIS). Arena Investors operates as an investment manager.

TSXV:WED - Post by User

Westaim Corp

Bullboard Posts

Post by ticktalkeron Mar 02, 2005 6:35pm

532 Views

Post# 8684713

Reminder

The superbug/acticoat article was published on Jan 17 2005. It states: "The full findings are expected to be published in a leading medical journal in the next few months." Since a few months are almost up, I would expect this to come out soon. My hope is that it will appear in the New England Journal of Medicine which comes out every Thursday evening. If it does, it will get a lot of press. My second choice would be JAMA. https://news.bbc.co.uk/2/hi/health/4172207.stm

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity